Reference health

Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants

https://doi.org/10.1002/pros.23298
CiteStamped reference-health badge
30/30 checkable references clean · checked 2026-08-20

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 30 checked references that resolve
resolves10.3322/caac.21254
Cancer statistics, 2015
resolves10.1016/j.urolonc.2015.01.008
Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinations
resolves10.1016/j.ctrv.2013.09.011
Castration-resistant prostate cancer: Adaptive responses in the androgen axis
resolves10.1016/j.ucl.2012.07.003
Targeting the Androgen Receptor
resolves10.1056/NEJMoa1209096
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
resolves10.1056/NEJMoa1405095
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
resolves10.1016/j.cell.2013.07.029
A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer
resolves10.7554/eLife.00499
Overcoming mutation-based resistance to antiandrogens with rational drug design
resolves10.1158/0008-5472.CAN-12-3630
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
resolves10.1056/NEJMoa1315815
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
resolves10.1056/NEJMoa1014618
Abiraterone and Increased Survival in Metastatic Prostate Cancer
resolves10.1056/NEJMoa1207506
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
resolves10.1126/scitranslmed.3004334
A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
resolves10.1158/0008-5472.CAN-07-1077
Triptolide Induces Pancreatic Cancer Cell Death via Inhibition of Heat Shock Protein 70
resolves10.1371/journal.pone.0077411
Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
resolves10.1016/j.surg.2014.04.055
Sorafenib and triptolide as combination therapy for hepatocellular carcinoma
resolves10.1016/j.canlet.2013.02.050
Minnelide reduces tumor burden in preclinical models of osteosarcoma
resolves10.1371/journal.pone.0037693
Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression
resolves10.7314/APJCP.2013.14.10.5663
Triptolide Inhibits Histone Methyltransferase EZH2 and Modulates the Expression of Its Target Genes in Prostate Cancer Cells
resolves10.1007/s11033-012-1737-2
Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation
resolves10.1074/jbc.M113.500983
Triptolide-induced Cell Death in Pancreatic Cancer Is Mediated by O-GlcNAc Modification of Transcription Factor Sp1
resolves10.1038/onc.2011.637
AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
resolves10.1111/j.1464-410X.2012.11445.x
Targeting the androgen receptor signalling axis in castration‐resistant prostate cancer (CRPC)
resolves10.1158/0008-5472.CAN-08-3795
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth
resolves10.1158/1078-0432.CCR-08-0531
Delineation of <i>TMPRSS2-ERG</i> Splice Variants in Prostate Cancer
resolves10.1007/s12672-014-0171-4
Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues
resolves10.1158/1535-7163.MCT-09-0549
Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA
resolves10.1038/nchembio.522
XPB, a subunit of TFIIH, is a target of the natural product triptolide
resolves10.1002/jcb.23359
KLF6/Sp1 initiates transcription of the <i>tmsg</i>‐1 gene in human prostate carcinoma cells: An exon involved mechanism
resolves10.1371/journal.pone.0035130
Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-20 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1002/pros.23298"><img src="https://citestamp.com/citestamped/10.1002/pros.23298/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1002/pros.23298/badge.svg)](https://citestamp.com/citestamped/10.1002/pros.23298)